RTW INVESTMENTS, LP - Q3 2013 holdings

Add to watchlist

All
New
Buy
Sell
Exit
Unchanged
 Value Shares↓ Weighting
No holdings reported for quarter Q3 2013
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ALNYLAM PHARMACEUTICALS INC36Q3 202319.7%
MASIMO CORP32Q3 20235.8%
LA JOLLA PHARMACEUTICAL CO31Q2 20229.7%
REGENXBIO INC30Q4 202210.8%
AGENUS INC29Q2 20229.0%
PTC THERAPEUTICS INC28Q3 202312.8%
DICERNA PHARMACEUTICALS INC28Q3 202110.8%
MIRATI THERAPEUTICS INC26Q3 20236.2%
ARGENX SE26Q3 20235.3%
VERICEL CORP24Q3 20233.9%

View RTW INVESTMENTS, LP's complete holdings history.

Latest significant ownerships (13-D/G)
RTW INVESTMENTS, LP Q3 2013 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
ROCKET PHARMACEUTICALS, INC.September 19, 202318,188,457-
ALLURION TECHNOLOGIES, INC.August 11, 20233,457,7077.4%
Orchestra BioMed Holdings, Inc.May 05, 20235,620,64515.7%
Renovacor, Inc.Sold outApril 05, 20230-
Adverum Biotechnologies, Inc.Sold outFebruary 14, 202300.0%
Aptevo Therapeutics Inc.Sold outFebruary 14, 202300.0%
ASLAN Pharmaceuticals LtdSold outFebruary 14, 202300.0%
Athira Pharma, Inc.Sold outFebruary 14, 202300.0%
BELLUS Health Inc.Sold outFebruary 14, 202300.0%
Clearside Biomedical, Inc.Sold outFebruary 14, 202300.0%

View RTW INVESTMENTS, LP's complete significant-ownership history.

Latest filings
TypeFiled
SC 13D/A2024-04-17
SC 13D/A2024-03-01
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View RTW INVESTMENTS, LP's complete filings history.

All filings

View complete filings history.

Compare quarters

Export RTW INVESTMENTS, LP's holdings

CSVXLS